Androgen-regulated metabolism and biosynthesis in prostate cancer

Area of Science:

• Oncology
• Metabolic pathways
• Cancer biology

Background:

• Metabolic alterations are a key feature of cancer, influenced by oncogenes and tumor suppressors.
• Steroid hormone biosynthesis and lipid metabolism are critical in prostate cancer (PCa) and represent therapeutic targets.
• The androgen receptor (AR) is essential for prostate development and tumorigenesis.

Purpose of the Study:

• To define the biological impact of the AR on prostate cancer.
• To systematically identify AR-regulated gene networks and whole-genome binding sites in PCa.

Main Methods:

• Genome-wide analysis of androgen receptor (AR) binding sites.
• Identification of AR-regulated gene networks in prostate cancer (PCa).
• Analysis of metabolic and biosynthesis pathways influenced by AR.

Main Results:

• The AR influences metabolism and biosynthesis at critical regulatory steps in PCa.
• AR-regulated metabolic pathways overlap with those affected by other oncogenes (e.g., c-Myc, p53) in various cancers.
• AR signaling impacts key metabolic pathways relevant to cancer progression.

Conclusions:

• The androgen receptor (AR) plays a significant role in regulating cancer metabolism in prostate cancer (PCa).
• Therapeutic strategies targeting AR-regulated metabolic pathways require careful management of stress and survival responses.
• Defining therapeutic windows is crucial for effective treatment of prostate cancer.